HealthRx vs embody vs wellmedr: Three Ways to Pay for GLP-1
Last updated: Aug 16, 2026
We may earn a commission when you visit providers through links on this page - it never affects our rankings (how we stay objective). This content is for information only and is not medical advice - always consult a licensed clinician before starting treatment.
Here’s the short version
Same compounded semaglutide, three opposite ways to buy it. HealthRx wants the year upfront - $1,188 at checkout, working out to $99/month with overnight cold-chain shipping. embody bills $69 monthly with the right to stop anytime. wellmedr bills monthly too, but its $59 rate locks on a 12-month plan. This is the clearest commitment-structure comparison in the market, and the right answer depends on exactly one thing: how certain you are about the next twelve months.
GLP-1 program from $99/month - clinician consult to overnight delivery
Visit HealthRx
HealthRx vs embody vs wellmedr: side by side
Real published prices and terms - the differences that actually decide this matchup.
| HealthRx | embody | wellmedr | |
|---|---|---|---|
| Semaglutide | $99/mo on a 12-month prepaid plan ($1,188 at checkout) | $69/mo, flat at every dose | $59/mo (12-month plan), same price at every dose |
| Tirzepatide | from $179/mo | $119/mo | $99/mo |
| Billing & commitment | 12-month prepaid - full year due at checkout | Monthly - no commitment, cancel anytime | Monthly billing - best rate locks on a 12-month plan |
| Shipping | Free overnight cold-chain, lot-tracked | Free 1-2 day, tracked & insured | Free, every 4 weeks, discreet packaging |
| Support | Care-team check-ins; clinician review on every request | Licensed doctors, medical director & nursing team | Medical Weight-Care Coach on every plan |
| Guarantee / refund | Free assessment - no payment to start | Full refund if you're not approved | Weight-loss warranty (terms on site) |
| Standout | LegitScript-certified (cert. 50087439); 503A pharmacies | LegitScript-certified; 503A pharmacies | 1M+ patients; board-certified specialists |
Our verdict
Certain about the year and cash-flow comfortable: HealthRx's prepaid $99 buys the best logistics in our ranking (overnight, lot-tracked). Certain about the year but prefer monthly billing: wellmedr's $59 lock is the best per-month rate anywhere. Not certain yet: embody - $69, no strings, refund if not approved - and revisit the committed options once your first months settle the question. Starting flexible and committing later costs surprisingly little.
HealthRx vs embody vs wellmedr: FAQs
Is HealthRx's $99/month real?
Yes, with a structure to understand: it's a 12-month prepaid semaglutide plan - $1,188 due at checkout - that works out to $99/month, including the clinician consult, overnight cold-chain shipping and dose adjustments. Tirzepatide plans start at $179/month. HealthRx is LegitScript-certified (cert. 50087439).
Which of the three is safest to try first?
embody carries the least commitment risk: flat $69/month, cancel anytime, and a full refund if a provider doesn't approve you. That makes it the natural first step if you haven't used GLP-1 medication before and want to confirm fit before committing a year anywhere.
What's the cheapest over a full year?
At listed rates for semaglutide: wellmedr $708/year ($59 x 12, billed monthly on a 12-month plan), embody $828 ($69 flat), HealthRx $1,188 (prepaid upfront). HealthRx's premium over the other two buys overnight cold-chain delivery on every shipment.
Sources & medical references
Treatment facts on this page are grounded in regulatory guidance and peer-reviewed research. Pricing and plan details come from each provider's published information.
- 1.Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 trial) - New England Journal of Medicine, 2021
- 2.Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1 trial) - New England Journal of Medicine, 2022
- 3.FDA Approves New Drug Treatment for Chronic Weight Management (semaglutide / Wegovy) - U.S. Food & Drug Administration, 2021
- 4.FDA Approves New Medication for Chronic Weight Management (tirzepatide / Zepbound) - U.S. Food & Drug Administration, 2023
- 5.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss - U.S. Food & Drug Administration
- 6.Human Drug Compounding (503A pharmacy standards) - U.S. Food & Drug Administration
- 7.Semaglutide Injection - drug information - MedlinePlus, U.S. National Library of Medicine (NIH)